The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers
about
Equol: pharmacokinetics and biological actionsEquol: history, chemistry, and formationThe chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancerEquol, a Dietary Daidzein Gut Metabolite Attenuates Microglial Activation and Potentiates Neuroprotection In VitroPharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps.Equol, via dietary sources or intestinal production, may ameliorate estrogen deficiency-induced bone lossCautions and research needs identified at the equol, soy, and menopause research leadership conferenceThe metabolism and analysis of isoflavones and other dietary polyphenols in foods and biological systems.Estrogen receptor and PI3K/Akt signaling pathway involvement in S-(-)equol-induced activation of Nrf2/ARE in endothelial cellsImpact of perinatal exposure to equol enantiomers on reproductive development in rodents.Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer riskAnalysis of urinary estrogens, their oxidized metabolites, and other endogenous steroids by benchtop orbitrap LCMS versus traditional quadrupole GCMS.Comparative effects of R- and S-equol and implication of transactivation functions (AF-1 and AF-2) in estrogen receptor-induced transcriptional activity.Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial.Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trialEndogenous and exogenous equol are antiestrogenic in reproductive tissues of apolipoprotein e-null mice.Equol inhibits growth, induces atresia, and inhibits steroidogenesis of mouse antral follicles in vitro.Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments.Possible role of S-equol on bone loss via amelioration of inflammatory indices in ovariectomized mice.Equol production changes over time in postmenopausal women.Pharmacokinetics of equol, a soy isoflavone metabolite, changes with the form of equol (dietary versus intestinal production) in ovariectomized ratsProtective effects of equol and their polyphenolic isomers against dermal aging: microarray/protein evidence with clinical implications and unique delivery into human skin.Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.Calcium-41: a technology for monitoring changes in bone mineral.The phytoestrogens daidzein and equol inhibit the drug transporter BCRP/ABCG2 in breast cancer cells: potential chemosensitizing effect.Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor β-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women.
P2860
Q24594626-40EA00D8-E01F-4A04-B88E-D26BBFF97601Q24594674-391A19F6-422E-4144-83CC-E8F22CD8A1DFQ24628910-551E882F-A760-444E-8919-8657BD1BCAFBQ29248888-F4972EDC-4525-4D22-9EA1-526911D88C83Q30841046-6DAD63A7-1CA2-475D-A512-3615B3D41039Q33908748-B9D9377D-1C1F-4D1D-8CB2-45B5635CA6A5Q33908755-D569C496-5A0E-4D80-A97C-3DBAD447C5D0Q34005314-149D5A46-FDF4-4398-969A-1FE4F2FE9941Q35048199-566B9AE4-C593-459E-B5D2-F9D017570AEEQ35234941-846624F8-091E-40FA-A3EC-A19DD7B81158Q35335557-BF284B9A-D37B-46DE-B97E-45FA82249DD8Q35643914-08196563-5CC7-4DA8-A932-A99C6B624A62Q35670918-DA54A700-A3D3-49F6-96D3-1AF1D3038F18Q35914108-70D3425B-7DA3-4380-8D64-17040F8364FAQ35992562-94F0F199-6EAF-417F-9CEC-96290BD56E59Q36235285-B96121ED-D4BE-42F9-B023-5EB2D270E352Q36655771-F361DEDC-2894-455C-9F64-4D3C03DE0D7EQ36902122-4EB095CB-0187-4A0A-B7D1-2A927D324EB5Q36993533-EB7E5742-2DF5-459C-B2F0-6B1609594D93Q37512708-7B23E4AD-976B-4232-9000-D11BCAE106FCQ37697453-92F88A3C-4CCD-4206-AF1C-BB87E429E922Q38314044-87502228-26F0-4965-8B7A-AED4303F9AD0Q38663475-6D423854-2C99-4298-B028-A568AFAA0BABQ39032494-86D2A2EE-7BD8-4B93-AF2F-E585559AE2E4Q47442621-8632F88C-E4AF-48F0-B259-9EEB3B38F589Q48106159-F79D2B3E-0EAF-4BFE-9895-33F77CC67716
P2860
The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The pharmacokinetic behavior o ...... stable-isotope-labeled tracers
@ast
The pharmacokinetic behavior o ...... stable-isotope-labeled tracers
@en
The pharmacokinetic behavior o ...... stable-isotope-labeled tracers
@nl
type
label
The pharmacokinetic behavior o ...... stable-isotope-labeled tracers
@ast
The pharmacokinetic behavior o ...... stable-isotope-labeled tracers
@en
The pharmacokinetic behavior o ...... stable-isotope-labeled tracers
@nl
prefLabel
The pharmacokinetic behavior o ...... stable-isotope-labeled tracers
@ast
The pharmacokinetic behavior o ...... stable-isotope-labeled tracers
@en
The pharmacokinetic behavior o ...... stable-isotope-labeled tracers
@nl
P2093
P2860
P356
P1476
The pharmacokinetic behavior o ...... stable-isotope-labeled tracers
@en
P2093
James E Heubi
Kenneth Dr Setchell
Nadine M Brown
Xueheng Zhao
P2860
P304
P356
10.3945/AJCN.2009.27981
P407
P577
2009-10-01T00:00:00Z